Correction: Antipsychotic‑Related Prolactin Changes: A Systematic Review and Dose–Response Meta‑analysis

Correction: CNS Drugs (2025) 39:937–947 10.1007/s40263-025-01218-z

In this article, Fig. 1 appeared incorrectly and have now been corrected in the original publication. For completeness and transparency, the old incorrect and the correct versions are given below.

Incorrect version:

Fig. 1 Prolactin change of individual antipsychotics in different dosages in participants with acute exacerbations of chronic schizophrenia. The dose–response curve depicts the mean differences of prolactin (ng/mL) comparing a given dose of a drug with 0 mg/day or placebo. The area between 95% confidence intervals is shaded in gray. The knot locations are set at the 25th, 50th, and 75th percentiles to anchor the curve. Different formulations are pooled in aripiprazole, paliperidone, quetiapine, and risperidone studies. n. studies number of studies, n. arms number of arms, N number of participants

Correct version:

Fig. 1 Prolactin change of individual antipsychotics in different dosages in participants with acute exacerbations of chronic schizophrenia. The dose–response curve depicts the mean differences of prolactin (ng/mL) comparing a given dose of a drug with 0 mg/day or placebo. The area between 95% confidence intervals is shaded in gray. The knot locations are set at the 25th, 50th, and 75th percentiles to anchor the curve. Different formulations are pooled in aripiprazole, paliperidone, quetiapine, and risperidone studies. n. studies number of studies, n. arms number of arms, N number of participants

The original article has been corrected.